You are here

  • Home
  • Archive
  • Volume 21, Issue 8
  • The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma

Article info

Article menu
Download PDFPDF
Cervical Cancer
The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma

Authors

  1. Address correspondence and reprint requests to Kiyoshi Hasegawa, MD, PhD, Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho Toyoake, Aichi, 470-1192, Japan. E-mail: khase{at}fujita-hu.ac.jp.

Citation

Hasegawa K, Kato R, Torii Y, et al
The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma
International Journal of Gynecologic Cancer 2011;21:1479-1485.

Publication history

  • Received March 2, 2011
  • First published November 1, 2011.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2011 by IGCS and ESGO